101 related articles for article (PubMed ID: 2666051)
1. Detection of ras gene alterations and ras proteins in colorectal cancer.
Salhab N; Jones DJ; Bos JL; Kinsella A; Schofield PF
Dis Colon Rectum; 1989 Aug; 32(8):659-64. PubMed ID: 2666051
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
[TBL] [Abstract][Full Text] [Related]
3. Independent prognostic value of ploidy in colorectal cancer. A prospective study using image cytometry.
Albe X; Vassilakos P; Helfer-Guarnori K; Givel JC; de Quay N; Suardet L; Eliason JF; Odartchenko N
Cancer; 1990 Sep; 66(6):1168-75. PubMed ID: 2400968
[TBL] [Abstract][Full Text] [Related]
4. Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas.
Czerniak B; Cohen GL; Etkind P; Deitch D; Simmons H; Herz F; Koss LG
Hum Pathol; 1992 Nov; 23(11):1199-204. PubMed ID: 1427748
[TBL] [Abstract][Full Text] [Related]
5. ras p21 expression in relation to DNA ploidy, S-phase fraction and prognosis in colorectal adenocarcinoma.
Sun XF; Wingren S; Carstensen JM; Stål O; Hatschek T; Boeryd B; Nordenskjöld B; Zhang H
Eur J Cancer; 1991; 27(12):1646-9. PubMed ID: 1782077
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern.
Scott NA; Wieand HS; Moertel CG; Cha SS; Beart RW; Lieber MM
Arch Surg; 1987 Dec; 122(12):1375-9. PubMed ID: 3689111
[TBL] [Abstract][Full Text] [Related]
7. DNA in situ sensitivity to denaturation: a new parameter for flow cytometry of normal human colonic epithelium and colon carcinoma.
Kunicka JE; Darzynkiewicz Z; Melamed MR
Cancer Res; 1987 Aug; 47(15):3942-7. PubMed ID: 3607742
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical study of oncogene-related products in human gastrointestinal malignancies--expression of ras p 21, fes p 85 and EGF receptor].
Kitagami S; Itabashi M; Hirota T; Hayashi I; Hojo K; Moriya Y; Maruyama K; Okabayashi K
Gan No Rinsho; 1986 Dec; 32(15):1950-8. PubMed ID: 2433473
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Ki-ras gene mutations associated with DNA diploid, aneuploid, and multiploid colorectal carcinomas using a crypt isolation technique.
Sugai T; Habano W; Nakamura S; Jiao YF; Higuchi T; Inomata M; Chiba T
Cytometry; 2001 Dec; 46(6):345-50. PubMed ID: 11754204
[TBL] [Abstract][Full Text] [Related]
10. [Molecular oncological study on DNA ploidy, Ki-ras point mutation, and p21 expression in colorectal cancer].
Yamazaki K; Sato K; Hirata S; Ikeda K; Kubo Y; Matsui H; Ogawa K
Nihon Geka Gakkai Zasshi; 1994 Apr; 95(4):242-7. PubMed ID: 8196591
[TBL] [Abstract][Full Text] [Related]
11. Differential activation of the c-Ki-ras-2 proto-oncogene in human colorectal carcinoma.
Halatsch ME; Hirsch-Ernst KI; Weinel RJ; Kahl GF
Anticancer Res; 1998; 18(4A):2323-5. PubMed ID: 9703874
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms.
Williams AR; Piris J; Spandidos DA; Wyllie AH
Br J Cancer; 1985 Nov; 52(5):687-93. PubMed ID: 3904801
[TBL] [Abstract][Full Text] [Related]
13. ras mutations and expression in head and neck squamous cell carcinomas.
Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
[TBL] [Abstract][Full Text] [Related]
14. Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers.
Hollstein MC; Smits AM; Galiana C; Yamasaki H; Bos JL; Mandard A; Partensky C; Montesano R
Cancer Res; 1988 Sep; 48(18):5119-23. PubMed ID: 3044581
[TBL] [Abstract][Full Text] [Related]
15. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
[TBL] [Abstract][Full Text] [Related]
16. c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis.
Bell SM; Kelly SA; Hoyle JA; Lewis FA; Taylor GR; Thompson H; Dixon MF; Quirke P
Br J Cancer; 1991 Jul; 64(1):174-8. PubMed ID: 1854618
[TBL] [Abstract][Full Text] [Related]
17. Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay.
Fukumoto M; Estensen RD; Sha L; Oakley GJ; Twiggs LB; Adcock LL; Carson LF; Roninson IB
Cancer Res; 1989 Apr; 49(7):1693-7. PubMed ID: 2647292
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
[TBL] [Abstract][Full Text] [Related]
19. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
[TBL] [Abstract][Full Text] [Related]
20. Clinico-pathological study of K-ras mutations in colorectal tumors in Saudi Arabia.
Zahrani A; Kandil M; Badar T; Abdelsalam M; Al-Faiar A; Ismail A
Tumori; 2014; 100(1):75-9. PubMed ID: 24675495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
